Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Cash from Discontinued Operations (2022 - 2023)

Vycor Medical (VYCO) has disclosed Cash from Discontinued Operations for 2 consecutive years, with 143.0 as the latest value for Q4 2023.

  • Quarterly Cash from Discontinued Operations rose 55.59% to 143.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was 772.0 through Dec 2023, up 146.53% year-over-year, with the annual reading at 636.0 for FY2025, 154.4% up from the prior year.
  • Cash from Discontinued Operations for Q4 2023 was 143.0 at Vycor Medical, down from 423.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 785.0 in Q2 2023, with the low at 1116.0 in Q2 2022.